• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Al Franken

Marathon’s defense of pricey orphan drug getting spotlight in Congress; running a marathon is far easier, and a lot cheaper

Steve Walker    March 9, 2017 May 7, 2018    1 Comment on Marathon’s defense of pricey orphan drug getting spotlight in Congress; running a marathon is far easier, and a lot cheaper

Steve’s Take: Marathon Pharmaceuticals LLC (Northbrook IL) caught my attention last month at the inception of an outcry when the company first announced the $89,000 price tag for its newly… Read more »

Corporate, Pharmaceuticals    Al Franken, Bernie Sanders, Bloomberg, Chuck Grassley, Cory Booker, Deflazacort, Duchenne Muscular Dystrophy, Elijah Cummings, Emflaza, Fierce Pharma, Government Accountability Office, Jeffrey Aronin, Marathon Pharmaceuticals LLC, Medscape, Motley Fool, MSNBC, Orphan Drug Act, Orrin Hatch, Patty Murray, PTC Ther­a­peu­tics, Stu­art Peltz, Tammy Baldwin, The Tufts Center for the Study of Drug Development, Tom Cotton, Wanda Moebus

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Top Stories for Week of January 18, 2021
  • Top Stories for Week of January 11, 2021
  • Top Stories for Week of January 4, 2021
  • Top Stories for Week of December 21, 2020
    • China records more than 2,000 new coronavirus cases in 24 hours; CDC director says CIVUD-19 probably with us beyond this
    • Top Stories for Week of June 8, 2020
    • Top Stories for Week of August 10, 2020
    • Top Stories for Week of October 5, 2020
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress